Lawmakers promised cancer patients would be protected from Medicaid cuts. Now CMS says otherwise
-
By
-
Gwen Nichols
-
June 4, 2026
-
0 min
By
Gwen Nichols
June 4, 2026
by Gwen Nichols
June 4, 2026
Dana-Farber Cancer Institute’s adult stem cell transplant program and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center’s pediatric stem cell transplant program have once again received exceptional ratings from the Center for International Blood & Marrow Transplant Research (CIBMTR), earning a +1 performance score, the highest possible designation, on their annual center-specific survival reports.
December 17, 2025